²ÝÝ®ÊÓƵ

Skip to main content

Position Statements

The ²ÝÝ®ÊÓƵ (AMS) is a scientific society with over 1,000 members from scientific, medical, nursing, pharmaceutical, paramedical and lay backgrounds interested in menopause education and research.

AMS and partner societies rigorously assess issues that may arise in managing menopause and publish position statements where required.

Title
Title Created Date
ESHRE Guideline on premature ovarian insufficiency 2025-02-17
The 2022 Hormone Therapy Position Statement of the North American Menopause Society 2022-07-09
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention 2022-01-19
Global consensus recommendations on menopause in the workplace 2021-08-26
Position Statement on Improving Bone Health and Osteoporosis Management in Australia 2021-05-28
HRT and Breast Cancer Risk Position Statement 2020-08-23
International consensus on testosterone treatment for women 2019-09-02
Sexual well-being after menopause: an International Menopause Society White Paper 2018-10-15
Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy 2018-07-27
Heavy Menstrual Bleeding Clinical Care Standard 2017 2017-12-07
NAMS 2017 position statement updates guidelines for hormone therapy use 2017-07-03
Management of menopausal symptoms in women with a history of breast cancer 2016-12-14
Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016 2016-11-29
Revised Global Consensus Statement on Menopausal Hormone Therapy 2016-09-06
A model of care for healthy menopause and ageing: EMAS position statement 2016-07-26
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms 2015-05-25
Scientific Definitions for Menopause Related Terminology 2008-08-03